Catheter ablation versus antiarrhythmic drugs with risk factor modification for treatment of atrial fibrillation: a protocol of a randomised controlled trial (PRAGUE-25 trial)

• Stepan Havranek,
• Jiri Jarkovsky,
• Otakar Jiravský,
• Pavel Osmancik,
• Veronika Bulková,
• Jan Chovančík,
• Tomáš Roubíček,
• Dalibor Heřman,
• Zuzana Čarná,
• Vladimír Tuka,
• Martin Matoulek,
• Martin Fiala,
• Sylvie Stregl-Hruskova,
• Adam Latiňák,
• Jiřina Kotryová

Affiliations

Stepan Havranek

1 2nd Department of Internal Cardiovascular Medicine, Charles University First Faculty of Medicine, Praha, Czech Republic

Jiri Jarkovsky

Department of Addictology, First Faculty of Medicine, Charles University, Prague, Czech Republic

Otakar Jiravský

2Kardiocentrum Podlesí, Trinec

Pavel Osmancik

Department of Cardiology, Kralovske Vinohrady University Hospital, Prague, Czech Republic

Veronika Bulková

Department of Cardiology, University Hospital Brno, Brno, Czech Republic

Jan Chovančík

Department of Cardiology, Charles University, Prague, Czech Republic

Tomáš Roubíček

Department of Cardiology, Regional Hospital Liberec, Liberec, Czech Republic

Dalibor Heřman

Department of Cardiology, Kralovske Vinohrady University Hospital, Prague, Czech Republic

Zuzana Čarná

Department of Cardiology, Kralovske Vinohrady University Hospital, Prague, Czech Republic

Vladimír Tuka

Cardiocenter, Second Internal Clinic-Cardiology and Angiology, Charles University, General Faculty Hospital, Prague, Prague, Czech Republic

Martin Matoulek

Cardiocenter, Second Internal Clinic-Cardiology and Angiology, Charles University, General Faculty Hospital, Prague, Prague, Czech Republic

Martin Fiala

Department of Cardiology, University Hospital Brno, Brno, Czech Republic

Sylvie Stregl-Hruskova

Department of Cardiology, Regional Hospital Liberec, Liberec, Czech Republic

Adam Latiňák

Department of Cardiology, Regional Hospital Liberec, Liberec, Czech Republic

Jiřina Kotryová

Masaryk University, Brno, Czech Republic